Neuroblastoma: oncogenic mechanisms and therapeutic exploitation of necroptosis
Open Access
- 3 December 2015
- journal article
- review article
- Published by Springer Science and Business Media LLC in Cell Death & Disease
- Vol. 6 (12), e2010
- https://doi.org/10.1038/cddis.2015.354
Abstract
Neuroblastoma (NB) is the most common extracranial childhood tumor classified in five stages (1, 2, 3, 4 and 4S), two of which (3 and 4) identify chemotherapy-resistant, highly aggressive disease. High-risk NB frequently displays MYCN amplification, mutations in ALK and ATRX, and genomic rearrangements in TERT genes. These NB subtypes are also characterized by reduced susceptibility to programmed cell death induced by chemotherapeutic drugs. The latter feature is a major cause of failure in the treatment of advanced NB patients. Thus, proper reactivation of apoptosis or of other types of programmed cell death pathways in response to treatment is relevant for the clinical management of aggressive forms of NB. In this short review, we will discuss the most relevant genomic rearrangements that define high-risk NB and the role that destabilization of p53 and p73 can have in NB aggressiveness. In addition, we will propose a strategy to stabilize p53 and p73 by using specific inhibitors of their ubiquitin-dependent degradation. Finally, we will introduce necroptosis as an alternative strategy to kill NB cells and increase tumor immunogenicity.Keywords
This publication has 160 references indexed in Scilit:
- Tumor suppressor WWOX binds to ΔNp63α and sensitizes cancer cells to chemotherapyCell Death & Disease, 2013
- Association of Age at Diagnosis and Genetic Mutations in Patients With NeuroblastomaJama-Journal Of The American Medical Association, 2012
- Mixed Lineage Kinase Domain-like Protein Mediates Necrosis Signaling Downstream of RIP3 KinaseCell, 2012
- Age-dependent accumulation of genomic aberrations and deregulation of cell cycle and telomerase genes in metastatic neuroblastomaInternational Journal of Cancer, 2012
- Emerging importance of ALK in neuroblastomaSeminars in Cancer Biology, 2011
- Beclin1 Controls the Levels of p53 by Regulating the Deubiquitination Activity of USP10 and USP13Cell, 2011
- Phosphorylation-Driven Assembly of the RIP1-RIP3 Complex Regulates Programmed Necrosis and Virus-Induced InflammationCell, 2009
- Receptor Interacting Protein Kinase-3 Determines Cellular Necrotic Response to TNF-αCell, 2009
- The HECT Family of E3 Ubiquitin Ligases: Multiple Players in Cancer DevelopmentCancer Cell, 2008
- p63 and p73 are required for p53-dependent apoptosis in response to DNA damageNature, 2002